(R)-Methanandamide and 9 -tetrahydrocannabinol-induced operant rate decreases in rats are not readily antagonized by SR-141716A

By Jarbe T.U.C.   Lamb R.J.   Liu Q.   Makriyannis A.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 121-127

Elsevier

Access to resources Recommend Favorite

Effects of the cannabinoid CB 1 receptor antagonist, SR141716A, after 9 -tetrahydrocannabinol withdrawal

By Beardsley P.M.   Martin B.R.  

European Journal of Pharmacology, Vol. 387, Iss. 1, 2000-11 ,pp. : 47-53

Elsevier

Access to resources Recommend Favorite

Discriminative stimulus effects of the cannabinoid CB₁ antagonist SR 141716A in rhesus monkeys pretreated with ∆⁹-tetrahydrocannabinol

By McMahon Lance  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 306-314

Springer Publishing Company

Access to resources Recommend Favorite

Chronic (-)- 9 -tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

By Gorriti M.A.   Rodrguez de Fonseca F.   Navarro M.   Palomo T.  

European Journal of Pharmacology, Vol. 365, Iss. 2, 1999-01 ,pp. : 133-142

Elsevier

Access to resources Recommend Favorite

The cannabinoid receptor antagonist SR-141716 does not readily antagonize open-field effects induced by the cannabinoid receptor agonist (R)-methanandamide in rats

By Jarbe T.U.C.   DiPatrizio N.V.   Li C.   Makriyannis A.  

Pharmacology Biochemistry and Behavior, Vol. 75, Iss. 4, 2003-07 ,pp. : 809-821

Elsevier

Access to resources Recommend Favorite